drug study paraccetamol
TRANSCRIPT
TAGUM DOCTORS COLLEGECollege of Nursing
DRUG STUDY
Name of Patient: Cornelio, Ignacio Room/Bed No: 336 Age: 43years oldPhysician: Dr. Dalmacio Gender:Male Admitting Diagnosis:sutured laceration; CVADate/ Shift
Name of Drug/ Drawing
Classification
Dosage/ Time/ Route
Mechanism of Action Side Effects Nursing Responsibilities
011-17-11
11-7
Brand name:Paracetamol IVTTDrawing:
Belongs to the class of bisphosphonates. Used in the treatment of bone diseases.
300mg/ every 4 hours/ IVTT
Zoledronic acid belongs to the class of nitrogen-containing bisphosphonates and acts primarily on bone. It is an inhibitor of osteoclast-mediated bone resorption. The selective action of bisphosphonates on bone is based on their high affinity for mineralized bone. IV administered zoledronic acid is rapidly distributed to bone and, like other bisphosphonates, localizes preferentially at sites of high bone turnover. The main molecular target of zoledronic acid in the osteoclast is the enzyme farnesyl pyrophosphate (FPP) synthase, but this does not exclude other
Headache, dizziness, nausea, vomiting, diarrhea, myalgia, arthralgia, bone & back pain, pain in extremities, fever, flu-like symptoms, chills, fatigue, asthenia, malaise, rigors.
Monitor VS before and after administration
Monitor fluid intake and output during treatment.
Provide water matress to prevent bed sores
Encourage the patient to move his extremities slowly
Provide calm, clean and quiet environment for faster healing.
Instruct patient not to drink alcohol or caffeine during te treatment.
CRITERIA:Content, Organization, and Accuracy of facts….............…. ..65Drawing…………………….…….10Neatness and punctuality………10Reference…………….....….……10TOTAL...………….….......………85
mechanisms. The relatively long duration of action of zoledronic acid is attributable to its high binding affinity for the active site of farnesyl pyrophosphate synthase and its strong binding affinity to bone mineral.
Name of Student: Kristen Kay Granada, SN Name of the Clinical Instructor: Mrs. Emily Lagura, RN, MN
Reference: Chan, W.M (2006).MIMS 10th Ed. CMPMedia.Philippines. pp16,120,382